No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
472 |
4. Check minimum number of eventsNone |
472 |
5. Include endpointsNone |
472 |
6. Filter based on genotype QC (FinnGen only) |
432 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Measles, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Viral infections characterized by skin and mucous membrane lesions, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 432 | 250 | 182 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.08 |
| Median age at first event (years) | 8.21 | 8.42 | 7.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 444
- Matched controls
- 4440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
05599
ICD-8 Finland
Measles, Non definita
+∞
273.1
233
*
05597
ICD-8 Finland
Measles, Suspecta
+∞
155.6
140
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
9.5
53.2
68
83
48609
ICD-8 Finland
Pneumonia, unspecified
10.5
31.6
36
37
0559X
ICD-9 Finland
Measles without mention of complication
+∞
19.9
19
*
48509
ICD-8 Finland
Bronchopneumonia, unspecified
7.8
19.7
28
38
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
4.0
19.0
58
160
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
4.2
16.1
45
116
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
5.5
15.1
30
58
B05.9
ICD-10 Finland
Measles without complication
+∞
13.6
13
*
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
5.6
12.4
24
45
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.5
12.1
23
23
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.4
10.6
85
403
05209
ICD-8 Finland
Chickenpox, Unspecified
+∞
9.4
9
*
A10AB05
ATC
insulin aspart; parenteral
3.0
8.8
40
142
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
4.9
8.7
19
40
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
4.1
8.4
23
58
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.4
8.3
21
50
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
8.0
101
569
07999
ICD-8 Finland
Other viral diseases, Viral infection, unspecified
13.3
7.9
13
10
A10AE04
ATC
insulin glargine; parenteral
2.7
7.9
43
169
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
7.8
102
582
S01AD03
ATC
aciclovir; ophthalmic
4.5
7.8
19
44
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
81.4
7.4
8
*
T89
ICPC
Diabetes insulin dependent
3.1
7.2
30
101
H02AB06
ATC
prednisolone; systemic
1.7
6.9
211
1546
SPAT1310
SPAT
Counselling related to known health issue
1.8
6.8
117
726
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
6.6
77
420
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
6.3
45
201
B05
ICD-10 Finland
Measles
+∞
6.3
6
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
6.2
80
451
A03FA02
ATC
cisapride; oral, rectal
2.9
6.2
29
105
R03BA02
ATC
budesonide; inhalant
1.9
6.2
90
529
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.4
6.1
22
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
125
740
1.96
8.65
2.7
2.1
2.81
2.75
mg/l
0.14
109
650
167
1106
1.82
8.07
4.1
3.1
8.06
8.88
mmol/l
1.59
146
976
151
1005
1.76
6.98
5.3
3.8
8.22
6.83
mg/mmol
0.17
100
621
79
427
2.03
6.96
3.9
2.6
24.35
24.70
%
0.07
74
402
166
1161
1.69
6.29
3.0
3.4
2.34
2.35
mmol/l
0.77
154
1095
137
910
1.73
6.27
1.7
1.8
0.61
0.82
mg/l
0.97
111
703
188
1375
1.64
5.90
2.1
1.8
97.67
98.14
pmol/l
0.05
115
785
68
378
1.94
5.49
2.0
1.6
1213.67
1149.69
nmol/l
0.28
60
308
191
1453
1.55
4.81
6.3
4.9
36.36
37.47
g/l
2.06
182
1399
240
1927
1.53
4.69
3.9
3.0
135.18
108.93
ug/l
1.01
232
1860
117
804
1.62
4.52
1.8
1.5
17.24
21.22
nmol/l
2.54
107
734
23
88
2.70
4.47
1.5
2.1
1.54
1.41
g/l
0.26
23
77
103
701
1.61
4.10
2.8
3.0
708.79
602.00
ng/l
0.11
81
560
42
219
2.01
4.08
1.9
1.6
—
—
—
0
0
206
1638
1.48
3.99
3.0
2.5
71.50
73.54
nmol/l
0.44
194
1564
139
1026
1.52
3.85
2.6
2.2
334.90
328.08
umol/l
0.35
127
963
131
955
1.53
3.85
4.3
3.3
0.00
0.00
estimate
0.50
50
333
13
36
3.69
3.52
1.7
1.2
—
—
—
0
0
84
575
1.57
3.23
2.5
2.7
2.42
2.42
mmol/l
0.13
76
521
46
269
1.79
3.20
3.6
3.0
—
—
—
0
0
15
56
2.74
3.09
1.1
1.3
—
—
—
0
0
236
1992
1.39
3.00
5.8
5.0
7.02
6.51
mmol/l
1.89
227
1903
228
1924
1.38
2.85
4.0
3.0
0.00
0.02
estimate
0.78
46
327
89
634
1.51
2.85
1.8
1.6
489.27
42367491.77
pmol/l
1.01
78
583
16
65
2.52
2.82
2.4
2.1
8.17
8.39
kpa
0.31
16
65
62
410
1.60
2.76
1.9
2.2
320.36
367.01
nmol/l
1.66
55
391
142
1118
1.40
2.66
4.2
2.8
—
—
—
0
0
46
286
1.68
2.61
4.8
3.5
5.94
5.84
kpa
0.29
46
281
318
2858
1.40
2.57
5.2
4.1
11.08
8.55
mm/h
2.65
301
2744
15
62
2.47
2.56
4.5
3.2
—
1111.67
—
0
6
225
1917
1.35
2.55
4.0
3.0
0.02
3.93
estimate
0.49
54
352
147
1172
1.38
2.54
4.2
2.7
55.13
60.66
u/l
0.65
141
1118
223
1898
1.35
2.54
4.0
3.0
0.00
0.01
estimate
0.80
54
344
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
64
2.39
2.41
3.4
3.5
0.32
0.34
iu/ml
—
10
32
10
34
2.98
2.29
1.3
1.8
—
—
—
0
0
12
47
2.60
2.29
1.1
1.2
—
—
—
0
0
8
24
3.37
2.19
3.6
2.7
662.38
642.63
u/ml
—
8
24
57
391
1.53
2.19
6.8
8.9
103.61
104.58
mmol/l
0.84
57
391
16
74
2.21
2.17
1.3
1.3
—
—
—
0
0
23
124
1.90
2.11
1.4
1.3
—
—
—
0
0
6
15
4.04
2.04
2.3
1.7
109.15
99.80
nmol/24h
—
6
15
43
281
1.59
2.04
5.0
3.6
2.56
2.01
mmol/l
0.48
38
251
48
327
1.52
1.91
2.1
1.7
—
—
—
0
0
151
1254
1.31
1.91
3.5
2.8
31.88
29.37
ng/l
0.08
77
654
21
114
1.88
1.90
2.5
2.4
3.64
3.46
g/l
0.27
21
109
63
455
1.45
1.89
3.1
2.6
9.06
6.78
umol/l
0.29
56
405
121
985
1.31
1.75
1.4
1.3
1.07
1.89
u/ml
0.70
38
302
113
914
1.32
1.71
1.3
1.4
37.15
23.42
iu/ml
0.59
28
302
64
475
1.41
1.67
1.9
1.8
—
—
—
0
0
15
77
1.98
1.61
4.0
2.6
7.58
6.71
pmol/l
0.28
15
77
49
349
1.45
1.60
5.8
5.3
—
—
—
0
0
103
834
1.31
1.54
1.4
1.3
3.23
9.63
u/ml
1.38
38
380
88
698
1.33
1.53
1.7
2.0
1.39
1.37
%
0.10
78
643
61
457
1.39
1.52
2.2
1.8
—
—
—
0
0
22
132
1.70
1.49
1.7
1.6
1.72
1426.04
u/l
—
5
38
175
1520
1.25
1.48
3.5
2.9
0.02
0.02
estimate
0.01
47
294
23
140
1.68
1.48
1.9
1.4
—
—
—
0
0
45
321
1.45
1.47
2.2
1.7
—
—
—
0
0
244
2200
1.24
1.47
11.7
10.1
4.14
3.93
e9/l
0.70
221
1964
6
22
2.75
1.44
1.0
1.1
—
—
—
0
0
180
1573
1.24
1.44
3.5
2.6
—
—
estimate
—
0
0
69
533
1.35
1.43
2.0
1.9
—
—
—
0
0
40
282
1.46
1.40
3.6
4.1
4.53
4.60
pmol/l
0.18
28
251
9
43
2.12
1.31
1.2
2.1
—
—
—
0
0
16
91
1.79
1.30
1.1
1.1
9.17
2.55
u/ml
0.73
11
38
37
261
1.46
1.30
1.9
1.9
—
—
—
0
0
26
170
1.56
1.29
3.0
2.5
250.89
77.75
ng/l
1.03
20
146
102
845
1.27
1.28
3.6
2.6
0.17
0.29
e6/l
0.77
79
613
11
55
2.03
1.28
1.2
1.2
—
—
—
0
0
158
1376
1.23
1.28
9.6
6.6
1.20
1.21
mmol/l
0.75
149
1283
6
25
2.42
1.24
2.3
2.5
—
—
—
0
0
59
457
1.34
1.22
2.9
2.4
1.71
2.72
e6/l
0.79
27
204
43
317
1.39
1.20
5.2
12.0
0.56
1.06
mmol/l
0.35
37
260
127
1088
1.23
1.19
2.7
2.0
228.48
155.01
u/l
0.36
118
1050
6
26
2.33
1.19
1.2
1.1
—
—
—
0
0
93
774
1.25
1.13
3.5
2.2
—
—
—
0
0
10
51
1.98
1.12
1.2
1.2
—
—
—
0
0
63
501
1.30
1.09
2.7
2.3
0.77
0.99
e6/l
0.37
32
249
25
170
1.50
1.07
3.9
2.8
0.57
0.65
%
0.57
25
170
45
345
1.34
1.01
4.6
2.8
40.00
51.64
u/l
0.37
40
298
17
107
1.61
1.01
1.0
1.1
—
—
—
0
0
17
108
1.60
0.98
1.0
1.1
—
—
—
0
0
97
825
1.22
0.97
2.9
3.0
1.02
2.88
kg/l
0.50
61
541
7
36
1.96
0.97
1.1
1.2
—
80.00
—
0
5
210
1919
1.18
0.96
6.7
6.3
9.79
10.84
umol/l
1.49
205
1854
13
77
1.71
0.96
1.8
1.5
136.00
155.15
au/ml
—
6
22
9
51
1.78
0.95
1.7
2.3
—
—
—
0
0
30
218
1.40
0.94
1.8
1.9
—
—
—
0
0
105
905
1.21
0.92
1.6
1.5
—
—
—
0
0
47
370
1.30
0.90
5.0
3.8
29.40
30.57
%
0.28
35
283
6
29
2.08
0.89
1.0
1.7
—
—
—
0
0
13
79
1.67
0.89
1.3
1.4
0.22
0.84
g/l
0.76
13
74
13
79
1.67
0.89
1.4
1.8
—
—
—
0
0
13
79
1.67
0.89
2.1
1.7
—
—
—
0
0
191
1742
1.17
0.88
2.2
1.9
1.50
1.49
mmol/l
0.11
160
1573
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
40
310
1.32
0.86
1.5
1.4
—
—
—
0
0
73
614
1.23
0.82
3.6
3.3
107.63
246.25
ng/l
0.73
46
393
12
73
1.66
0.82
1.3
1.8
—
—
—
0
0
6
32
1.89
0.82
1.2
1.7
—
—
—
0
0
6
32
1.89
0.82
1.7
1.8
—
—
—
0
0
304
2884
1.17
0.82
10.0
7.7
79.99
76.70
u/l
0.67
295
2777
10
58
1.74
0.80
1.5
1.5
—
—
—
0
0
324
3092
1.18
0.80
4.7
4.4
14.51
14.32
pmol/l
0.88
311
2968
165
1498
1.16
0.79
4.1
3.4
32.30
30.76
u/l
0.30
159
1430
129
1150
1.17
0.78
3.3
2.6
0.00
0.02
estimate
1.23
43
284
17
115
1.50
0.78
1.1
1.1
0.66
2.40
u/ml
—
10
58
388
3766
1.24
0.77
15.8
10.9
89.99
89.63
ml/min/173m2
0.16
360
3515
36
281
1.31
0.75
2.3
2.3
73.07
77.52
ml/min/173m2
0.20
15
115
15
100
1.52
0.73
1.1
1.0
5.21
2.10
u/ml
—
9
50
386
3749
1.23
0.73
7.2
5.0
40.96
38.12
mmol/mol
4.80
373
3620
371
3590
1.20
0.73
5.5
5.2
1.70
1.77
mu/l
0.68
352
3462
7
39
1.81
0.72
1.3
1.2
—
—
—
0
0
7
39
1.81
0.72
1.3
1.2
—
—
—
0
0
9
56
1.62
0.72
1.9
1.1
—
—
—
0
0
9
56
1.62
0.72
2.4
1.5
—
—
—
0
0
9
56
1.62
0.72
1.9
1.1
—
—
—
0
0
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
14
93
1.52
0.70
3.4
2.4
354.03
302.03
ug/l
0.09
14
84
7
41
1.72
0.70
1.3
1.2
—
—
—
0
0
7
41
1.72
0.70
1.3
1.2
—
—
—
0
0
7
42
1.68
0.68
1.0
1.3
—
—
—
0
0
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
7
44
1.60
0.65
1.0
1.3
—
—
—
0
0
30
235
1.30
0.63
1.5
1.8
0.42
0.35
mg/l
0.18
14
118
14
199
0.69
0.63
1.6
1.6
—
—
—
0
0
39
317
1.25
0.62
2.4
2.4
15.15
18.36
au/ml
—
6
43
5
30
1.67
0.61
1.8
1.5
—
—
—
0
0
17
122
1.41
0.61
1.8
1.4
220.26
322.18
ug/g
—
9
69
23
175
1.33
0.59
6.6
14.7
1.36
1.59
%
0.63
23
175
398
3895
1.21
0.57
4.5
4.0
1.43
1.36
mmol/l
0.68
375
3748
23
178
1.31
0.54
7.2
14.6
94.40
93.60
%
0.34
23
178
11
75
1.48
0.51
2.2
3.2
1.40
2.19
index
—
5
43
7
45
1.56
0.49
1.3
1.2
—
—
—
0
0
167
1561
1.11
0.48
10.6
7.4
1.21
1.21
mmol/l
0.52
142
1365
17
128
1.34
0.48
1.5
1.6
0.26
0.24
g/l
0.37
17
121
7
47
1.50
0.47
1.3
1.4
—
—
—
0
0
7
47
1.50
0.47
1.1
1.7
1.23
1.39
nmol/l
—
7
40
22
173
1.29
0.47
7.5
14.8
0.80
0.68
%
0.69
22
173
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
56
490
1.16
0.45
1.4
1.4
28.00
31.37
iu/l
0.32
46
439
10
69
1.46
0.44
1.0
1.1
1.34
1.47
g/l
—
10
63
20
158
1.28
0.42
1.5
1.2
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
53
601
0.87
0.42
1.6
1.8
3.41
3.58
mmol/l
0.57
37
442
15
114
1.33
0.41
2.5
2.1
1.01
1.02
ratio
1.54
15
104
8
59
1.36
0.41
1.4
1.5
—
—
—
0
0
21
168
1.26
0.41
1.7
1.4
33.00
243.18
miu/ml
—
6
81
0
17
0.00
0.40
0.0
1.0
—
98.00
—
0
10
0
17
0.00
0.40
0.0
1.0
—
109.10
—
0
10
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.40
0.0
1.0
—
124.41
—
0
17
393
3862
1.15
0.40
18.9
12.3
19.86
20.25
mg/l
0.09
334
3082
10
71
1.42
0.39
1.0
1.3
0.00
0.00
g/l
—
10
63
5
35
1.43
0.39
1.8
2.1
1.03
0.67
e9/l
—
5
35
17
133
1.29
0.39
1.5
1.5
1.25
1.24
g/l
0.01
17
125
5
36
1.39
0.38
1.0
1.1
95.00
123.28
pmol/l
—
5
36
396
3896
1.15
0.38
19.1
12.7
139.49
139.80
mmol/l
2.20
388
3845
11
81
1.37
0.36
1.1
1.2
—
—
—
0
0
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
6
47
1.28
0.32
1.2
1.3
130.60
180.61
pmol/l
—
6
47
30
258
1.17
0.32
4.2
4.7
5.29
12.46
ug/l
0.55
15
199
10
75
1.34
0.30
1.7
1.5
—
—
—
0
0
79
731
1.10
0.29
1.5
1.5
—
—
—
0
0
23
195
1.19
0.29
1.7
1.6
—
—
—
0
0
381
3754
1.11
0.28
5.0
4.3
6.16
5.79
mmol/l
3.55
354
3596
17
140
1.22
0.28
2.5
1.6
—
—
—
0
0
85
909
0.92
0.26
2.8
3.0
18.22
22.06
%
2.34
28
268
429
4315
0.83
0.22
26.7
18.6
4.60
4.64
e12/l
1.04
424
4260
0
11
0.00
0.21
0.0
1.1
—
103.64
—
0
11
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
9.28
—
0
10
429
4314
0.84
0.21
26.7
18.7
264.83
259.77
e9/l
0.89
424
4261
429
4314
0.84
0.21
26.6
18.5
90.76
90.61
fl
0.31
424
4289
395
3909
1.10
0.21
19.6
12.8
3.93
3.95
mmol/l
0.53
387
3847
5
43
1.16
0.21
1.2
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
74
781
0.94
0.17
1.9
2.1
3.69
3.64
ratio
0.13
62
625
5
66
0.75
0.17
2.0
1.5
—
—
—
0
0
311
3063
1.05
0.16
3.4
3.4
—
—
—
0
0
27
244
1.11
0.16
1.1
1.1
—
—
—
0
0
409
4060
1.09
0.16
5.3
4.7
4.70
4.89
mmol/l
3.51
388
3946
326
3218
1.05
0.15
3.8
3.3
47.32
45.90
u/l
0.12
311
3141
30
326
0.91
0.14
1.1
1.3
142.33
139.32
u/ml
0.02
15
144
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
408
4056
1.07
0.12
5.3
4.7
1.40
1.44
mmol/l
1.21
387
3926
411
4087
1.08
0.11
5.8
5.0
2.79
2.96
mmol/l
3.80
388
3960
17
188
0.90
0.11
2.9
1.9
190.00
206.99
pmol/l
0.30
17
178
12
105
1.15
0.11
1.1
1.3
—
—
—
0
0
417
4189
0.93
0.10
13.6
10.6
29.29
29.45
u/l
0.07
409
4136
30
319
0.94
0.09
1.3
1.2
0.82
0.90
g/l
1.89
30
319
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
30
318
0.94
0.08
1.3
1.1
1.42
1.53
g/l
2.05
30
318
5
61
0.82
0.08
1.0
1.2
7.98
7.73
mmol/l
—
5
55
71
733
0.96
0.08
2.4
2.3
0.61
0.62
ug/l
0.06
31
325
21
195
1.08
0.08
1.7
2.1
9.50
7.43
iu/ml
—
6
46
8
76
1.05
0.07
1.9
1.2
—
—
—
0
0
16
147
1.09
0.07
2.6
1.7
—
—
—
0
0
23
216
1.07
0.07
1.3
1.7
312.06
291.87
mu/l
0.09
18
203
112
1129
0.99
0.01
3.0
3.2
1.56
1.36
ug/l
0.50
105
1050
22
226
0.97
0.00
1.6
1.4
—
—
—
0
0
10
105
0.95
0.00
2.1
1.7
—
—
—
0
0
17
171
0.99
0.00
1.1
1.4
12.64
9.96
u/l
0.21
11
148
18
181
0.99
0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
1.18
—
0
9
5
49
1.02
-0.00
1.8
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
47
470
1.00
-0.00
2.4
2.4
13.15
14.33
nmol/l
0.56
42
450
8
83
0.96
-0.00
3.2
2.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.4
—
0.43
—
0
7
7
69
1.01
-0.00
7.7
6.5
413.71
364.53
umol/l
—
7
62
8
80
1.00
-0.00
1.3
1.1
—
2.12
—
0
20
0
7
0.00
-0.00
0.0
1.6
—
5.77
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.4
1.6
—
—
—
0
0
9
95
0.95
-0.00
2.2
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_MEASLES_WIDE – Measles, including avohilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).